APA

Schulz S. C., Zanarini M. C., Bateman A., Bohus M., Detke H. C., Trzaskoma Q., Tanaka Y., Lin D., Deberdt W. & Corya S. (20090205). Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. : The British journal of psychiatry : the journal of mental science.

Chicago

Schulz S Charles, Zanarini Mary C, Bateman Anthony, Bohus Martin, Detke Holland C, Trzaskoma Quynh, Tanaka Yoko, Lin Daniel, Deberdt Walter and Corya Sara. 20090205. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. : The British journal of psychiatry : the journal of mental science.

Harvard

Schulz S. C., Zanarini M. C., Bateman A., Bohus M., Detke H. C., Trzaskoma Q., Tanaka Y., Lin D., Deberdt W. and Corya S. (20090205). Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. : The British journal of psychiatry : the journal of mental science.

MLA

Schulz S Charles, Zanarini Mary C, Bateman Anthony, Bohus Martin, Detke Holland C, Trzaskoma Quynh, Tanaka Yoko, Lin Daniel, Deberdt Walter and Corya Sara. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. : The British journal of psychiatry : the journal of mental science. 20090205.